Ascendis Pharma A/S

NASDAQ (USD): Ascendis Pharma A/S (ASND)

Last Price

124.33

Today's Change

-2.22 (1.75%)

Day's Change

124.11 - 127.99

Trading Volume

381,853

Overview

Market Cap

7 Billion

Shares Outstanding

57 Million

Avg Volume

636,745

Avg Price (50 Days)

132.53

Avg Price (200 Days)

137.32

PE Ratio

-13.18

EPS

-9.43

Earnings Announcement

07-Nov-2024

Previous Close

126.55

Open

127.40

Day's Range

124.11 - 127.99

Year Range

86.545 - 161.0

Trading Volume

381,853

Price Change Highlight

1 Day Change

-1.75%

5 Day Change

-2.26%

1 Month Change

-3.84%

3 Month Change

-2.08%

6 Month Change

-6.61%

Ytd Change

-2.51%

1 Year Change

35.04%

3 Year Change

-21.68%

5 Year Change

9.76%

10 Year Change

560.28%

Max Change

560.28%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment